Literature DB >> 1429564

1.9-A resolution structure of fasciculin 1, an anti-acetylcholinesterase toxin from green mamba snake venom.

M H le Du1, P Marchot, P E Bougis, J C Fontecilla-Camps.   

Abstract

The crystal structure of fasciculin 1, a potent acetylcholinesterase inhibitor from green mamba snake venom, has been solved by the multiple isomorphous replacement method complemented with anomalous scattering and subsequently refined at 1.9-A resolution. The overall structure of fasciculin is similar to those of the short alpha-neurotoxins and cardiotoxins, with a dense core rich in disulfide bridges and three long loops disposed as the central fingers of a hand. A comparison of these three prototypic toxin types shows that fasciculin 1 has structural features that are intermediate between those of the other two molecules. Its core region, which can be defined as a continuous stretch of conserved residues, is very similar to that of erabutoxin b, whereas the orientation of its long loops resembles that of cardiotoxin VII4. This result introduces a new element in the study of phylogenetic relationships of snake toxins and suggests that, after divergency from an ancestral gene, convergent evolution may have played an important factor in the evolution of these proteins. In fasciculin 1, several arginine and lysine residues are well ordered and relatively exposed to the solvent medium and may play a role in the binding to the peripheral site of acetylcholinesterases.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1429564     DOI: 10.2210/pdb1fas/pdb

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  9 in total

1.  Structural insights into ligand interactions at the acetylcholinesterase peripheral anionic site.

Authors:  Yves Bourne; Palmer Taylor; Zoran Radić; Pascale Marchot
Journal:  EMBO J       Date:  2003-01-02       Impact factor: 11.598

2.  Conformational transitions in protein-protein association: binding of fasciculin-2 to acetylcholinesterase.

Authors:  Jennifer M Bui; Zoran Radic; Palmer Taylor; J Andrew McCammon
Journal:  Biophys J       Date:  2006-02-10       Impact factor: 4.033

3.  Mapping conformational dynamics of proteins using torsional dynamics simulations.

Authors:  Vamshi K Gangupomu; Jeffrey R Wagner; In-Hee Park; Abhinandan Jain; Nagarajan Vaidehi
Journal:  Biophys J       Date:  2013-05-07       Impact factor: 4.033

Review 4.  Chemistry and Enzymology of Disulfide Cross-Linking in Proteins.

Authors:  Deborah Fass; Colin Thorpe
Journal:  Chem Rev       Date:  2017-07-12       Impact factor: 60.622

5.  The structure of Escherichia coli heat-stable enterotoxin b by nuclear magnetic resonance and circular dichroism.

Authors:  M Sukumar; J Rizo; M Wall; L A Dreyfus; Y M Kupersztoch; L M Gierasch
Journal:  Protein Sci       Date:  1995-09       Impact factor: 6.725

6.  Interaction of synthetic peptides from fasciculin with acetylcholinesterase.

Authors:  R J Falkenstein; C Peña
Journal:  J Protein Chem       Date:  1999-02

7.  Isolation and pharmacological characterization of AdTx1, a natural peptide displaying specific insurmountable antagonism of the alpha1A-adrenoceptor.

Authors:  L Quinton; E Girard; A Maiga; M Rekik; P Lluel; G Masuyer; M Larregola; C Marquer; J Ciolek; T Magnin; R Wagner; J Molgó; R Thai; C Fruchart-Gaillard; G Mourier; J Chamot-Rooke; A Ménez; S Palea; D Servent; N Gilles
Journal:  Br J Pharmacol       Date:  2009-12-15       Impact factor: 8.739

8.  Soluble monomeric acetylcholinesterase from mouse: expression, purification, and crystallization in complex with fasciculin.

Authors:  P Marchot; R B Ravelli; M L Raves; Y Bourne; D C Vellom; J Kanter; S Camp; J L Sussman; P Taylor
Journal:  Protein Sci       Date:  1996-04       Impact factor: 6.725

9.  Theoretical analysis of the structure of the peptide fasciculin and its docking to acetylcholinesterase.

Authors:  H K van den Born; Z Radić; P Marchot; P Taylor; I Tsigelny
Journal:  Protein Sci       Date:  1995-04       Impact factor: 6.725

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.